Vir Biotechnology, Inc. Common Stock

VIRNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
11.08 USD
↗ 0.37 (3.46%)AT CLOSE (11:59 AM EDT)
10.53
↘ 0.55 (4.95%)
POST MARKET (AS OF 06:47 PM EDT)
Post Market
AS OF 06:47 PM EDT
10.53
↘ 0.55 (4.95%)
🟢Market: OPEN

VIR is currently priced at $10.53. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, VIR trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 26, 2026.

Open?$10.60
High?$11.12
Low?$10.30
Prev. Close?$10.71
Volume?2.2M
Avg. Volume?1.6M
VWAP?$10.69
Rel. Volume?1.43x
Bid / Ask
Bid?$8.88 × 100
Ask?$12.85 × 100
Spread?$3.97
Midpoint?$10.87
Valuation & Ratios
Market Cap?1.8B
Shares Out?169.2M
Float?130.8M
Float %?77.6%
P/E Ratio?N/A
P/B Ratio?1.84
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Themes
Biotech - Drug Development›Infectious Disease & VaccinesHealthcare - Oncology›Targeted Therapy & Precision OncologyAI & Machine Learning›AI-Powered Analytics & Decision Systems
Employees
367
Market Cap
1.8B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.vir.bio
Listed
2019-10-11
Address
1800 OWENS STREET
SAN FRANCISCO, CA 94158
Phone: 415-906-4324
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
77
Momentum?
50
Short Sent.?
28
Piotroski F-Score?4/9Mixed
Altman Z-Score?3.21Safe
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?14.98%High
Short Interest?19.6M
Days to Cover?13.6
Free Float130.8M
Avg Daily Volume1.4M
Settlement Date2026-08-14
Financial Health
Current Ratio?6.04Strong
Quick Ratio?6.04Strong
Cash Ratio?2.94Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
79
1.84CHEAP▾
P/S?
Peers
100
S&P
22
5.98FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-5.7CHEAP▾
EV/Sales?
Peers
100
S&P
36
5.06FAIR▾
Returns & Efficiency
ROE?
S&P
7
-25.6%WEAK▾
ROA?
S&P
3
-20.7%WEAK▾
Cash Flow & Enterprise
FCF?$-203593000
Enterprise Value?$1.5B
Fundamentals ratios updated end of day
MarketsMoversWatchlist